 | • レポートコード：MR2211MG12624 • 出版社/出版日：Market Monitor Global / 2022年11月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2-3日） • 産業分類：製薬・ヘルスケア |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥625,300 (USD4,225) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は次の情報を含め、抗侵襲性真菌症（IFI）治療薬のグローバル市場規模と予測を記載しています。・抗侵襲性真菌症（IFI）治療薬のグローバル市場：売上、2017年-2022年、2023年-2028年 ・抗侵襲性真菌症（IFI）治療薬のグローバル市場：販売量、2017年-2022年、2023年-2028年 ・世界のトップ5企業、2021年 抗侵襲性真菌症（IFI）治療薬のグローバル市場規模は2021年に000Mドルと評価され、予測期間中に000％のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「経口用抗真菌薬」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。 抗侵襲性真菌症（IFI）治療薬のグローバル主要企業は、Pfizer、 Merck & Co., Inc、 GSK、 Novartis、 Bayer、 Abbott、 Sanofi-Aventis、 Enzon Pharmaceuticals、 Astellas Pharma、 Sato Pharmaceutical、 Eisai Co., Ltd.、 Sichuan Meida Kanghuakang Pharmaceutical、 Zhejiang Huahai Pharmaceutical、 Huasun Technology、 Yangtze River Pharmaceutical、 Yantai Luyin Pharmaceutical、 Xian Janssen Pharmaceuticalなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。 マーケットモニターグローバル（MMG）社は、抗侵襲性真菌症（IFI）治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の抗侵襲性真菌症（IFI）治療薬市場：タイプ別、2017年-2022年、2023年-2028年 世界の抗侵襲性真菌症（IFI）治療薬市場：タイプ別市場シェア、2021年 ・経口用抗真菌薬、外用抗真菌薬、注射用抗真菌薬 世界の抗侵襲性真菌症（IFI）治療薬市場：用途別、2017年-2022年、2023年-2028年 世界の抗侵襲性真菌症（IFI）治療薬市場：用途別市場シェア、2021年 ・病院薬局、小売薬局、クリニック薬局、その他 世界の抗侵襲性真菌症（IFI）治療薬市場：地域・国別、2017年-2022年、2023年-2028年 世界の抗侵襲性真菌症（IFI）治療薬市場：地域別市場シェア、2021年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における抗侵襲性真菌症（IFI）治療薬のグローバル売上、2017年-2022年 ・主要企業における抗侵襲性真菌症（IFI）治療薬のグローバル売上シェア、2021年 ・主要企業における抗侵襲性真菌症（IFI）治療薬のグローバル販売量、2017年-2022年 ・主要企業における抗侵襲性真菌症（IFI）治療薬のグローバル販売量シェア、2021年 さらに、当レポートは主要企業のプロファイルを提示します。 Pfizer、 Merck & Co., Inc、 GSK、 Novartis、 Bayer、 Abbott、 Sanofi-Aventis、 Enzon Pharmaceuticals、 Astellas Pharma、 Sato Pharmaceutical、 Eisai Co., Ltd.、 Sichuan Meida Kanghuakang Pharmaceutical、 Zhejiang Huahai Pharmaceutical、 Huasun Technology、 Yangtze River Pharmaceutical、 Yantai Luyin Pharmaceutical、 Xian Janssen Pharmaceutical ************************************************************* ・調査・分析レポートの概要 抗侵襲性真菌症（IFI）治療薬市場の定義 市場セグメント 世界の抗侵襲性真菌症（IFI）治療薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の抗侵襲性真菌症（IFI）治療薬市場規模 世界の抗侵襲性真菌症（IFI）治療薬市場規模：2021年 VS 2028年 世界の抗侵襲性真菌症（IFI）治療薬市場規模と予測 2017年-2028年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの抗侵襲性真菌症（IFI）治療薬の売上 グローバルトップ3およびトップ5企業、2021年売上ベース グローバル企業の抗侵襲性真菌症（IFI）治療薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：経口用抗真菌薬、外用抗真菌薬、注射用抗真菌薬 抗侵襲性真菌症（IFI）治療薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院薬局、小売薬局、クリニック薬局、その他 抗侵襲性真菌症（IFI）治療薬の用途別グローバル売上・予測 ・地域別市場分析 地域別抗侵襲性真菌症（IFI）治療薬市場規模 2021年と2028年 地域別抗侵襲性真菌症（IFI）治療薬売上・予測 北米市場 - アメリカの抗侵襲性真菌症（IFI）治療薬市場規模2017年-2028年 - カナダの抗侵襲性真菌症（IFI）治療薬市場規模2017年-2028年 - メキシコの抗侵襲性真菌症（IFI）治療薬市場規模2017年-2028年 ヨーロッパ市場 - ドイツの抗侵襲性真菌症（IFI）治療薬市場規模2017年-2028年 - フランスの抗侵襲性真菌症（IFI）治療薬市場規模2017年-2028年 - イギリスの抗侵襲性真菌症（IFI）治療薬市場規模2017年-2028年 - イタリアの抗侵襲性真菌症（IFI）治療薬市場規模2017年-2028年 - ロシアの抗侵襲性真菌症（IFI）治療薬市場規模2017年-2028年 アジア市場 - 中国の抗侵襲性真菌症（IFI）治療薬市場規模2017年-2028年 - 日本の抗侵襲性真菌症（IFI）治療薬市場規模2017年-2028年 - 韓国の抗侵襲性真菌症（IFI）治療薬市場規模2017年-2028年 - 東南アジアの抗侵襲性真菌症（IFI）治療薬市場規模2017年-2028年 - インドの抗侵襲性真菌症（IFI）治療薬市場規模2017年-2028年 南米市場 - ブラジルの抗侵襲性真菌症（IFI）治療薬市場規模2017年-2028年 - アルゼンチンの抗侵襲性真菌症（IFI）治療薬市場規模2017年-2028年 中東・アフリカ市場 - トルコの抗侵襲性真菌症（IFI）治療薬市場規模2017年-2028年 - イスラエルの抗侵襲性真菌症（IFI）治療薬市場規模2017年-2028年 - サウジアラビアの抗侵襲性真菌症（IFI）治療薬市場規模2017年-2028年 - UAEの抗侵襲性真菌症（IFI）治療薬市場規模2017年-2028年 ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Pfizer、 Merck & Co., Inc、 GSK、 Novartis、 Bayer、 Abbott、 Sanofi-Aventis、 Enzon Pharmaceuticals、 Astellas Pharma、 Sato Pharmaceutical、 Eisai Co., Ltd.、 Sichuan Meida Kanghuakang Pharmaceutical、 Zhejiang Huahai Pharmaceutical、 Huasun Technology、 Yangtze River Pharmaceutical、 Yantai Luyin Pharmaceutical、 Xian Janssen Pharmaceutical ... |
This report contains market size and forecasts of Anti-invasive Fungal Infection (IFI) Drug in global, including the following market information:
Global Anti-invasive Fungal Infection (IFI) Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Anti-invasive Fungal Infection (IFI) Drug Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Anti-invasive Fungal Infection (IFI) Drug companies in 2021 (%)
The global Anti-invasive Fungal Infection (IFI) Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Anti-invasive Fungal Infection Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-invasive Fungal Infection (IFI) Drug include Pfizer, Merck & Co., Inc, GSK, Novartis, Bayer, Abbott, Sanofi-Aventis, Enzon Pharmaceuticals and Astellas Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-invasive Fungal Infection (IFI) Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-invasive Fungal Infection (IFI) Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-invasive Fungal Infection (IFI) Drug Market Segment Percentages, by Type, 2021 (%)
Oral Anti-invasive Fungal Infection Drug
Topical Anti-invasive Fungal Infection Drug
Injectable Anti-invasive Fungal Infection Drug
Global Anti-invasive Fungal Infection (IFI) Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-invasive Fungal Infection (IFI) Drug Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Retail Pharmacy
Clinic Pharmacy
Other
Global Anti-invasive Fungal Infection (IFI) Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-invasive Fungal Infection (IFI) Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-invasive Fungal Infection (IFI) Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Anti-invasive Fungal Infection (IFI) Drug revenues share in global market, 2021 (%)
Key companies Anti-invasive Fungal Infection (IFI) Drug sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Anti-invasive Fungal Infection (IFI) Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Merck & Co., Inc
GSK
Novartis
Bayer
Abbott
Sanofi-Aventis
Enzon Pharmaceuticals
Astellas Pharma
Sato Pharmaceutical
Eisai Co., Ltd.
Sichuan Meida Kanghuakang Pharmaceutical
Zhejiang Huahai Pharmaceutical
Huasun Technology
Yangtze River Pharmaceutical
Yantai Luyin Pharmaceutical
Xian Janssen Pharmaceutical
Brilliant Pharmaceutical
1 Introduction to Research & Analysis Reports
1.1 Anti-invasive Fungal Infection (IFI) Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-invasive Fungal Infection (IFI) Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-invasive Fungal Infection (IFI) Drug Overall Market Size
2.1 Global Anti-invasive Fungal Infection (IFI) Drug Market Size: 2021 VS 2028
2.2 Global Anti-invasive Fungal Infection (IFI) Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Anti-invasive Fungal Infection (IFI) Drug Sales: 2017-2028
3 Company Landscape
3.1 Top Anti-invasive Fungal Infection (IFI) Drug Players in Global Market
3.2 Top Global Anti-invasive Fungal Infection (IFI) Drug Companies Ranked by Revenue
3.3 Global Anti-invasive Fungal Infection (IFI) Drug Revenue by Companies
3.4 Global Anti-invasive Fungal Infection (IFI) Drug Sales by Companies
3.5 Global Anti-invasive Fungal Infection (IFI) Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Anti-invasive Fungal Infection (IFI) Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Anti-invasive Fungal Infection (IFI) Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-invasive Fungal Infection (IFI) Drug Players in Global Market
3.8.1 List of Global Tier 1 Anti-invasive Fungal Infection (IFI) Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-invasive Fungal Infection (IFI) Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Anti-invasive Fungal Infection (IFI) Drug Market Size Markets, 2021 & 2028
4.1.2 Oral Anti-invasive Fungal Infection Drug
4.1.3 Topical Anti-invasive Fungal Infection Drug
4.1.4 Injectable Anti-invasive Fungal Infection Drug
4.2 By Type – Global Anti-invasive Fungal Infection (IFI) Drug Revenue & Forecasts
4.2.1 By Type – Global Anti-invasive Fungal Infection (IFI) Drug Revenue, 2017-2022
4.2.2 By Type – Global Anti-invasive Fungal Infection (IFI) Drug Revenue, 2023-2028
4.2.3 By Type – Global Anti-invasive Fungal Infection (IFI) Drug Revenue Market Share, 2017-2028
4.3 By Type – Global Anti-invasive Fungal Infection (IFI) Drug Sales & Forecasts
4.3.1 By Type – Global Anti-invasive Fungal Infection (IFI) Drug Sales, 2017-2022
4.3.2 By Type – Global Anti-invasive Fungal Infection (IFI) Drug Sales, 2023-2028
4.3.3 By Type – Global Anti-invasive Fungal Infection (IFI) Drug Sales Market Share, 2017-2028
4.4 By Type – Global Anti-invasive Fungal Infection (IFI) Drug Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application – Global Anti-invasive Fungal Infection (IFI) Drug Market Size, 2021 & 2028
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Clinic Pharmacy
5.1.5 Other
5.2 By Application – Global Anti-invasive Fungal Infection (IFI) Drug Revenue & Forecasts
5.2.1 By Application – Global Anti-invasive Fungal Infection (IFI) Drug Revenue, 2017-2022
5.2.2 By Application – Global Anti-invasive Fungal Infection (IFI) Drug Revenue, 2023-2028
5.2.3 By Application – Global Anti-invasive Fungal Infection (IFI) Drug Revenue Market Share, 2017-2028
5.3 By Application – Global Anti-invasive Fungal Infection (IFI) Drug Sales & Forecasts
5.3.1 By Application – Global Anti-invasive Fungal Infection (IFI) Drug Sales, 2017-2022
5.3.2 By Application – Global Anti-invasive Fungal Infection (IFI) Drug Sales, 2023-2028
5.3.3 By Application – Global Anti-invasive Fungal Infection (IFI) Drug Sales Market Share, 2017-2028
5.4 By Application – Global Anti-invasive Fungal Infection (IFI) Drug Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region – Global Anti-invasive Fungal Infection (IFI) Drug Market Size, 2021 & 2028
6.2 By Region – Global Anti-invasive Fungal Infection (IFI) Drug Revenue & Forecasts
6.2.1 By Region – Global Anti-invasive Fungal Infection (IFI) Drug Revenue, 2017-2022
6.2.2 By Region – Global Anti-invasive Fungal Infection (IFI) Drug Revenue, 2023-2028
6.2.3 By Region – Global Anti-invasive Fungal Infection (IFI) Drug Revenue Market Share, 2017-2028
6.3 By Region – Global Anti-invasive Fungal Infection (IFI) Drug Sales & Forecasts
6.3.1 By Region – Global Anti-invasive Fungal Infection (IFI) Drug Sales, 2017-2022
6.3.2 By Region – Global Anti-invasive Fungal Infection (IFI) Drug Sales, 2023-2028
6.3.3 By Region – Global Anti-invasive Fungal Infection (IFI) Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country – North America Anti-invasive Fungal Infection (IFI) Drug Revenue, 2017-2028
6.4.2 By Country – North America Anti-invasive Fungal Infection (IFI) Drug Sales, 2017-2028
6.4.3 US Anti-invasive Fungal Infection (IFI) Drug Market Size, 2017-2028
6.4.4 Canada Anti-invasive Fungal Infection (IFI) Drug Market Size, 2017-2028
6.4.5 Mexico Anti-invasive Fungal Infection (IFI) Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country – Europe Anti-invasive Fungal Infection (IFI) Drug Revenue, 2017-2028
6.5.2 By Country – Europe Anti-invasive Fungal Infection (IFI) Drug Sales, 2017-2028
6.5.3 Germany Anti-invasive Fungal Infection (IFI) Drug Market Size, 2017-2028
6.5.4 France Anti-invasive Fungal Infection (IFI) Drug Market Size, 2017-2028
6.5.5 U.K. Anti-invasive Fungal Infection (IFI) Drug Market Size, 2017-2028
6.5.6 Italy Anti-invasive Fungal Infection (IFI) Drug Market Size, 2017-2028
6.5.7 Russia Anti-invasive Fungal Infection (IFI) Drug Market Size, 2017-2028
6.5.8 Nordic Countries Anti-invasive Fungal Infection (IFI) Drug Market Size, 2017-2028
6.5.9 Benelux Anti-invasive Fungal Infection (IFI) Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region – Asia Anti-invasive Fungal Infection (IFI) Drug Revenue, 2017-2028
6.6.2 By Region – Asia Anti-invasive Fungal Infection (IFI) Drug Sales, 2017-2028
6.6.3 China Anti-invasive Fungal Infection (IFI) Drug Market Size, 2017-2028
6.6.4 Japan Anti-invasive Fungal Infection (IFI) Drug Market Size, 2017-2028
6.6.5 South Korea Anti-invasive Fungal Infection (IFI) Drug Market Size, 2017-2028
6.6.6 Southeast Asia Anti-invasive Fungal Infection (IFI) Drug Market Size, 2017-2028
6.6.7 India Anti-invasive Fungal Infection (IFI) Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country – South America Anti-invasive Fungal Infection (IFI) Drug Revenue, 2017-2028
6.7.2 By Country – South America Anti-invasive Fungal Infection (IFI) Drug Sales, 2017-2028
6.7.3 Brazil Anti-invasive Fungal Infection (IFI) Drug Market Size, 2017-2028
6.7.4 Argentina Anti-invasive Fungal Infection (IFI) Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Anti-invasive Fungal Infection (IFI) Drug Revenue, 2017-2028
6.8.2 By Country – Middle East & Africa Anti-invasive Fungal Infection (IFI) Drug Sales, 2017-2028
6.8.3 Turkey Anti-invasive Fungal Infection (IFI) Drug Market Size, 2017-2028
6.8.4 Israel Anti-invasive Fungal Infection (IFI) Drug Market Size, 2017-2028
6.8.5 Saudi Arabia Anti-invasive Fungal Infection (IFI) Drug Market Size, 2017-2028
6.8.6 UAE Anti-invasive Fungal Infection (IFI) Drug Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Anti-invasive Fungal Infection (IFI) Drug Major Product Offerings
7.1.4 Pfizer Anti-invasive Fungal Infection (IFI) Drug Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 Merck & Co., Inc
7.2.1 Merck & Co., Inc Corporate Summary
7.2.2 Merck & Co., Inc Business Overview
7.2.3 Merck & Co., Inc Anti-invasive Fungal Infection (IFI) Drug Major Product Offerings
7.2.4 Merck & Co., Inc Anti-invasive Fungal Infection (IFI) Drug Sales and Revenue in Global (2017-2022)
7.2.5 Merck & Co., Inc Key News
7.3 GSK
7.3.1 GSK Corporate Summary
7.3.2 GSK Business Overview
7.3.3 GSK Anti-invasive Fungal Infection (IFI) Drug Major Product Offerings
7.3.4 GSK Anti-invasive Fungal Infection (IFI) Drug Sales and Revenue in Global (2017-2022)
7.3.5 GSK Key News
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Anti-invasive Fungal Infection (IFI) Drug Major Product Offerings
7.4.4 Novartis Anti-invasive Fungal Infection (IFI) Drug Sales and Revenue in Global (2017-2022)
7.4.5 Novartis Key News
7.5 Bayer
7.5.1 Bayer Corporate Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Anti-invasive Fungal Infection (IFI) Drug Major Product Offerings
7.5.4 Bayer Anti-invasive Fungal Infection (IFI) Drug Sales and Revenue in Global (2017-2022)
7.5.5 Bayer Key News
7.6 Abbott
7.6.1 Abbott Corporate Summary
7.6.2 Abbott Business Overview
7.6.3 Abbott Anti-invasive Fungal Infection (IFI) Drug Major Product Offerings
7.6.4 Abbott Anti-invasive Fungal Infection (IFI) Drug Sales and Revenue in Global (2017-2022)
7.6.5 Abbott Key News
7.7 Sanofi-Aventis
7.7.1 Sanofi-Aventis Corporate Summary
7.7.2 Sanofi-Aventis Business Overview
7.7.3 Sanofi-Aventis Anti-invasive Fungal Infection (IFI) Drug Major Product Offerings
7.7.4 Sanofi-Aventis Anti-invasive Fungal Infection (IFI) Drug Sales and Revenue in Global (2017-2022)
7.7.5 Sanofi-Aventis Key News
7.8 Enzon Pharmaceuticals
7.8.1 Enzon Pharmaceuticals Corporate Summary
7.8.2 Enzon Pharmaceuticals Business Overview
7.8.3 Enzon Pharmaceuticals Anti-invasive Fungal Infection (IFI) Drug Major Product Offerings
7.8.4 Enzon Pharmaceuticals Anti-invasive Fungal Infection (IFI) Drug Sales and Revenue in Global (2017-2022)
7.8.5 Enzon Pharmaceuticals Key News
7.9 Astellas Pharma
7.9.1 Astellas Pharma Corporate Summary
7.9.2 Astellas Pharma Business Overview
7.9.3 Astellas Pharma Anti-invasive Fungal Infection (IFI) Drug Major Product Offerings
7.9.4 Astellas Pharma Anti-invasive Fungal Infection (IFI) Drug Sales and Revenue in Global (2017-2022)
7.9.5 Astellas Pharma Key News
7.10 Sato Pharmaceutical
7.10.1 Sato Pharmaceutical Corporate Summary
7.10.2 Sato Pharmaceutical Business Overview
7.10.3 Sato Pharmaceutical Anti-invasive Fungal Infection (IFI) Drug Major Product Offerings
7.10.4 Sato Pharmaceutical Anti-invasive Fungal Infection (IFI) Drug Sales and Revenue in Global (2017-2022)
7.10.5 Sato Pharmaceutical Key News
7.11 Eisai Co., Ltd.
7.11.1 Eisai Co., Ltd. Corporate Summary
7.11.2 Eisai Co., Ltd. Anti-invasive Fungal Infection (IFI) Drug Business Overview
7.11.3 Eisai Co., Ltd. Anti-invasive Fungal Infection (IFI) Drug Major Product Offerings
7.11.4 Eisai Co., Ltd. Anti-invasive Fungal Infection (IFI) Drug Sales and Revenue in Global (2017-2022)
7.11.5 Eisai Co., Ltd. Key News
7.12 Sichuan Meida Kanghuakang Pharmaceutical
7.12.1 Sichuan Meida Kanghuakang Pharmaceutical Corporate Summary
7.12.2 Sichuan Meida Kanghuakang Pharmaceutical Anti-invasive Fungal Infection (IFI) Drug Business Overview
7.12.3 Sichuan Meida Kanghuakang Pharmaceutical Anti-invasive Fungal Infection (IFI) Drug Major Product Offerings
7.12.4 Sichuan Meida Kanghuakang Pharmaceutical Anti-invasive Fungal Infection (IFI) Drug Sales and Revenue in Global (2017-2022)
7.12.5 Sichuan Meida Kanghuakang Pharmaceutical Key News
7.13 Zhejiang Huahai Pharmaceutical
7.13.1 Zhejiang Huahai Pharmaceutical Corporate Summary
7.13.2 Zhejiang Huahai Pharmaceutical Anti-invasive Fungal Infection (IFI) Drug Business Overview
7.13.3 Zhejiang Huahai Pharmaceutical Anti-invasive Fungal Infection (IFI) Drug Major Product Offerings
7.13.4 Zhejiang Huahai Pharmaceutical Anti-invasive Fungal Infection (IFI) Drug Sales and Revenue in Global (2017-2022)
7.13.5 Zhejiang Huahai Pharmaceutical Key News
7.14 Huasun Technology
7.14.1 Huasun Technology Corporate Summary
7.14.2 Huasun Technology Business Overview
7.14.3 Huasun Technology Anti-invasive Fungal Infection (IFI) Drug Major Product Offerings
7.14.4 Huasun Technology Anti-invasive Fungal Infection (IFI) Drug Sales and Revenue in Global (2017-2022)
7.14.5 Huasun Technology Key News
7.15 Yangtze River Pharmaceutical
7.15.1 Yangtze River Pharmaceutical Corporate Summary
7.15.2 Yangtze River Pharmaceutical Business Overview
7.15.3 Yangtze River Pharmaceutical Anti-invasive Fungal Infection (IFI) Drug Major Product Offerings
7.15.4 Yangtze River Pharmaceutical Anti-invasive Fungal Infection (IFI) Drug Sales and Revenue in Global (2017-2022)
7.15.5 Yangtze River Pharmaceutical Key News
7.16 Yantai Luyin Pharmaceutical
7.16.1 Yantai Luyin Pharmaceutical Corporate Summary
7.16.2 Yantai Luyin Pharmaceutical Business Overview
7.16.3 Yantai Luyin Pharmaceutical Anti-invasive Fungal Infection (IFI) Drug Major Product Offerings
7.16.4 Yantai Luyin Pharmaceutical Anti-invasive Fungal Infection (IFI) Drug Sales and Revenue in Global (2017-2022)
7.16.5 Yantai Luyin Pharmaceutical Key News
7.17 Xian Janssen Pharmaceutical
7.17.1 Xian Janssen Pharmaceutical Corporate Summary
7.17.2 Xian Janssen Pharmaceutical Business Overview
7.17.3 Xian Janssen Pharmaceutical Anti-invasive Fungal Infection (IFI) Drug Major Product Offerings
7.17.4 Xian Janssen Pharmaceutical Anti-invasive Fungal Infection (IFI) Drug Sales and Revenue in Global (2017-2022)
7.17.5 Xian Janssen Pharmaceutical Key News
7.18 Brilliant Pharmaceutical
7.18.1 Brilliant Pharmaceutical Corporate Summary
7.18.2 Brilliant Pharmaceutical Business Overview
7.18.3 Brilliant Pharmaceutical Anti-invasive Fungal Infection (IFI) Drug Major Product Offerings
7.18.4 Brilliant Pharmaceutical Anti-invasive Fungal Infection (IFI) Drug Sales and Revenue in Global (2017-2022)
7.18.5 Brilliant Pharmaceutical Key News
8 Global Anti-invasive Fungal Infection (IFI) Drug Production Capacity, Analysis
8.1 Global Anti-invasive Fungal Infection (IFI) Drug Production Capacity, 2017-2028
8.2 Anti-invasive Fungal Infection (IFI) Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-invasive Fungal Infection (IFI) Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-invasive Fungal Infection (IFI) Drug Supply Chain Analysis
10.1 Anti-invasive Fungal Infection (IFI) Drug Industry Value Chain
10.2 Anti-invasive Fungal Infection (IFI) Drug Upstream Market
10.3 Anti-invasive Fungal Infection (IFI) Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-invasive Fungal Infection (IFI) Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer